MalaFA – Malaria Futures for Africa

http://youtu.be/h4PRcZ9_Tk8 Highlights from the launch of the Malaria Futures for Africa (MalaFA) study at the 2018 CHOGM Malaria Summit, London. MalaFA is an opinion research study commissioned by Novartis to capture the views of African malaria experts in 14 sub-Saharan African countries – from government, the research community and NGOs – on progress and remaining challenges toward the 2030 global malaria goals. Study co-chairs are Dr Richard Kamwi, Ambassador, Elimination 8 (E8), and Professor Bob Snow, of the KEMRI-Wellcome Trust programme, Kenya and University of Oxford, United Kingdom. Read the full report: http://bit.ly/MalaFA-report Learn more: http://socialbusiness.novartis.com © 2018 Novartis AG